DUSP1 and metabolic disease: The further use of conditional DUSP1/MKP-1 ablation will reveal the relative importance of MAPK regulation in distinct tissues by this phosphatase in energy homeostasis and, from the information gathered so far, MKP-1/DUSP1 continues to be a potential pharmacological target for the treatment of metabolic disease.